Oryzon Submits Phase III Trial Protocol For BPD Drug Vafidemstat To FDA

ReutersJun 23, 2025 6:15 AM

June 23 (Reuters) - Oryzon Genomics SA ORY.MC:

SUBMITS TO FDA CLINICAL TRIAL PROTOCOL FOR ITS PHASE III PORTICO-2 TRIAL OF VAFIDEMSTAT IN BORDERLINE PERSONALITY DISORDER (BPD) PATIENTS
PORTICO-2 TO EMPLOY TWO CLINICAL OUTCOME MEASURES FOR AGGRESSION AS PRIMARY ENDPOINT
TO EMPLOY OVERT AGGRESSION SCALE-MODIFIED (OAS-M) AS KEY SECONDARY ENDPOINT
ADDITIONAL SECONDARY ENDPOINTS TO EVALUATE BROADER CLINICAL IMPROVEMENTS IN BPD SYMPTOMATOLOGY AND LIFE QUALITY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

AMD's Road to $1,000: A Mathematical Possibility or a Cyclical Bubble?

AMD targets $1,000 by 2030, leveraging OpenAI and Meta partnerships. As data center revenue hits 52%, can AMD outrun its bubble?

Azure Growth 40%, AI Revenue 37 Billion: Why Did Microsoft Shares Fall Instead of Rise?

TradingKey - On April 29 (ET), Microsoft (MSFT) released its Q3 FY2026 results after the bell. Both revenue and profit exceeded expectations, with Azure growth returning to 40% and annualized AI revenue surpassing $37 billion. Despite this, shares fell more than 3% in after-hours trading and ended t

Amazon Q1 Earnings Deep Dive: AWS Revenue Growth Accelerates, AI Investment About to Enter Payoff Period, Stock Price May Rise to $300

TradingKey - Amazon achieved better-than-expected growth in its first-quarter results, driven by a re-acceleration in AWS revenue, the materialization of AI investments, and steady growth in its retail and advertising businesses.

AI Engines Roar at Full Power, Alphabet Cloud Business Grows 63%, Stock Surges 7% After Hours.

TradingKey - After the market close on Wednesday ET, Google parent Alphabet (GOOGL) (GOOG) reported its first-quarter earnings for 2026. Fully empowered by AI technology, the company saw accelerating growth across all business lines. Driven by stellar performance in its cloud business, both revenue and earnings for the period significantly exceeded market expectations. Following the announcement, the company’s shares rose by more than 7% in after-hours trading.

SanDisk Surges 8% as Earnings Countdown Begins - Here's What Every Investor Needs to Know

TradingKey - SanDisk(SNDK) is really on the move ahead of its earnings April 30th release, and the company's price action over the past few days is telling us there's something specific going on . It's currently up 8.11%, yesterday it jumped by 6.16%. A year ago it was hovering around the $28 mark,

Featured Tools